Hackensack Meridian Health has announced that Verda J. Hicks, MD, FACS, FACOG, will serve as its chief of Gynecologic Oncology at Jersey Shore University Medical Center. She will be joined by associates James R. Bosscher, MD, and Karim ElSahwi, MD, to facilitate promising experience and care to the Monmouth, Ocean, and Middlesex counties.
Verda J. Hicks, MD, FACS, FACOG
Verda J. Hicks, MD, FACS, FACOG
Hackensack Meridian Health has announced that Verda J. Hicks, MD, FACS, FACOG, will serve as its chief of Gynecologic Oncology at Jersey Shore University Medical Center. She will be joined by associates James R. Bosscher, MD, and Karim Elsahwi, MD, to facilitate promising experience and care to the Monmouth, Ocean, and Middlesex counties.
“The depth of knowledge and skill set that Dr Hicks brings to our organization is a wonderful addition to the comprehensive services that we offer local residents,” said Thomas Bauer, MD, interim medical director of Hackensack Meridian Health Cancer Care in Monmouth, Ocean and Middlesex counties in a statement. “The gynecologic oncology team blends personalized, compassionate care with the latest techniques and technologies for diagnosis and treatment. This is part of our ongoing commitment to offer quality cancer resources, close to home.”
Hicks will continue her position as medical director of Gynecologic Oncology for Hackensack Meridian Health Center in the 3-county region. In addition to her patient practice, she has served as a clinical professor in the department of OB/GYN at the University of Kansas School of Medicine and as an assistant professor of gynecologic oncology. She has also served as an associate professor of gynecologic oncology at the University of Missouri-Kansas City.
Among numerous honors, Hicks received consistent recognition as “Best Physicians of Kansas City” by her peers and a Colposcopy Recognition Award from the American Society of Colposcopy and Cervical Pathology, of which she is a member. She is also a member of the Society of Gynecologic Oncologists, the Kansas City Gynecological Society, and the Association of Professors of Gynecology and Obstetrics.
Hicks and her gynecologic oncology associates specialize in the treatment of a wide range of malignant and non-malignant conditions affecting the womens reproductive system. They provide a variety of procedures, including robotic surgery, laparoscopic surgery, ovarian, cervical and endometrial cancer, pelvic surgery, lymph nodes procedures, removal of reproductive organs and more. Additionally, patients have access to the most recent clinical trials and genetic counselling and testing.
KEYNOTE-A18 Supports Pembrolizumab and CRT as New Standard in High-Risk Cervical Cancer
September 14th 2024Pembrolizumab combined with chemoradiotherapy followed by pembrolizumab monotherapy significantly improved survival compared to chemoradiotherapy alone in patients with high-risk locally advanced cervical cancer.
Read More